Lyell Immunopharma (LYEL) Other Operating Expenses (2020 - 2025)
Historic Other Operating Expenses for Lyell Immunopharma (LYEL) over the last 6 years, with Q3 2025 value amounting to $1.6 million.
- Lyell Immunopharma's Other Operating Expenses rose 11794.52% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 6622.05%. This contributed to the annual value of $3.3 million for FY2024, which is 1860.22% up from last year.
- According to the latest figures from Q3 2025, Lyell Immunopharma's Other Operating Expenses is $1.6 million, which was up 11794.52% from -$1.1 million recorded in Q2 2025.
- In the past 5 years, Lyell Immunopharma's Other Operating Expenses ranged from a high of $1.6 million in Q3 2025 and a low of -$1.1 million during Q2 2025
- Its 5-year average for Other Operating Expenses is $727631.6, with a median of $758000.0 in 2021.
- In the last 5 years, Lyell Immunopharma's Other Operating Expenses soared by 42511.21% in 2022 and then crashed by 20881.15% in 2025.
- Lyell Immunopharma's Other Operating Expenses (Quarter) stood at $798000.0 in 2021, then surged by 51.63% to $1.2 million in 2022, then plummeted by 47.02% to $641000.0 in 2023, then dropped by 19.97% to $513000.0 in 2024, then skyrocketed by 210.14% to $1.6 million in 2025.
- Its Other Operating Expenses stands at $1.6 million for Q3 2025, versus -$1.1 million for Q2 2025 and $119000.0 for Q1 2025.